Toxicological Evaluation and Possible Reversal of Diabetic Toxicological Complications by PHF5 an Antidiabetic Herbal Formula in Wistar Albino Rats
Asian Journal of Research in Biochemistry,
Aim: Medicinal potentials of herbs can be amplified greatly through synergism in a poly-herbal formulations. Toxic propensities of a plant can be masked out in poly-herbal preparations thus enhancing effectiveness. The aim of this study was to evaluate the potential toxicological effect and toxicity ameliorating properties of a poly-herbal formula (PHF5) prepared in a particular ratio from the leaves of Ocimmum gratissimum, Vernonia amygdalina, Gongronema latifolium, Gnetum africanum and Aloe barbadensis against alloxan-induced diabetic male rats.
Methods: Thirty-six (36) Wistar rats divided into 6 groups with 6 animals per group were used for this study. Group 1 served as normal control animals; group 2 had the diabetic rats treated with PHF5 (75 mg/kg bw); group 3, diabetic rats treated with PHF5 (150 mg/kg bw); group 4, diabetic rats treated with PHF5 (300 mg/kg bw); group 5, diabetic rats not given any intervention, group 6 diabetic animals treated with Glibenclamide (5 mg/kgbw). The induction of diabetes was done intraperitoneally using alloxan monohydrate (100 mg/kg bw). Administration of PHF5 was done orally for five weeks.
Results: Acute toxicity studies of PHF5 did not show any toxic symptoms in animals that received the PHF5 at up to 5000 mg/kg bw dose. The elevated liver (TP, AST, ALT and ALP) and kidney (BUN and Creatnine) markers in the diabetic animals were lowered significantly in the PHF5-treated animals.
Conclusion: The findings of this study suggests that PHF5 possess protective properties against hepatotoxicity and diabetic nephropathy and that the extract is quite safe for consumption
- Wistar rats
- poly-herbal formula
- alloxan monohydrate
How to Cite
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. New England Journal of Medicine. 2008;359(15):1577-1589.
Gopinathan S, Naveenray D. World Journal of pharmaceutical Research. 2014; 3(6):1640-1675.
Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity and chronic oxidative stress in type 2 diabetes. Diabetes. 2004;53 (11):119-124.
Kaneto H, Katakami N, Kawamori D, Miyatsuka T, Sakamoto K, Matsuoka TA, et al. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxid. Redox Signal. 2007;9:355–366.
Stumvoll M, Goldstein BJ, Van- Haeften TW. Type 2 diabetes: Principles of pathogenesis and therapy. Lancet. 2005; 365:1333–1346.
Dokken BB. Diabetes Spectrum. 2008; 21:160-165.
Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: part I. European Heart Journal. 2013;34(31): 2436-2443.
Modak M, Dixit P, Londhe J, Ghaskadbi S, Thomas PA. Indian herbs and herbal drugs used for the treatment of diabetes. Journal of Clinical Biochemistry and Nutrition. 2007;40:163-173.
Ogugua VN, Egba SI, Adoga JE. In-vivo anti-oxidant and anti-hyperglycaemic properties of aqueous extract of herbal cocktail. Plant Products Research Journal. 2013;16:18-21
Zhang Y, Zhen W, Maechler P, LiuSmall D. Molecule kaempferol modulates PDX‑1 protein expression and subse‑ quently promotes pancreatic β‑cell survival and function via CREB. J Nutr Biochem. 2013; 24:638‑646.
Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: A review. J Diabetes Metab Disord. 2013;12(43):35.
Suriawinata AA, Thung SN. Liver pathology an Atlas and concise guide Latest Edition; 2011.
Bakris GL, Molitch M. Microalbuminuria as a risk predictor in diabetes: The continuing saga. Diabetes Care. 2014;37(3):867-875.
Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Harrison’s Principles of Internal Medicine. 18th ed. Vol. 2. New York, USA: McGraw-Hill; 2011.
Burtis CE, Ashwood D, Bruns, Tietz W. Tietz Fundamentals of Clinical Chemistry 6th ed. Philadelphia, PA Saunders; 2008.
Pecoits-Filho R, Abensur H, Betônico CC, Machado AD, Parente EB, Queiroz M, et al. Interactions between kidney disease and diabetes: Dangerous liaisons. Diabetology and Metabolic Syndrome. 2016;8(1):50.
Vallon V, Komers R. Pathophysiology of the diabetic kidney. Comprehensive Physiology. 2011;1(3):1175-1232.
Okoduwa SIR. Anti-diabetic potential of Ocimmum gratissimum leaf fractions in fortified diet-fed streptozotocin treated rat model of type-2 diabetes. Medicines. 2017; 4:73.
Iweala EE, Uhuegbu FO, Obidoa O. Biochemical and histological changes associated with long term consumption of gnetuum Africanum Welw. Leaves in Rats. Asian Journal of Biochemistry. 2009;4(4): 125-132.
Adeoye AT, Adedapo AA, Omobowale TO, Oyagbemi AA. Antioxidant activity of methanol leaf extract of vernoniaamygdalina in kidney of alloxan-induced diabetic rats. The FASEB Journal. 2017:31(1_supplement):lb564-lb564.
Chatterjee P, Mukherjee A, Nandy S. Protective effects of the aqueous leaf extract of Aloe barbadensis on gentamicin and cisplatin–induced nephrotoxic rats. Asian Pacific Journal of Tropical Biomedicine. 2012;2(3):S1754-S1763.
Abstract View: 55 times
PDF Download: 29 times